Charles E. Dann
Impact in
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms
- Wnt/β-catenin signaling in development and cancer
- Protein Structure and Dynamics
- Bacterial biofilms and quorum sensing
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Biochemical and Molecular Research 5
- Protein Structure and Dynamics 5
- RNA and protein synthesis mechanisms 4
-
- Folate and B Vitamins Research 6
- Co-authors
- Daniel J. Leahy (4 shared papers)Richard K. Bruick (2 shared papers)Wade C. Winkler (3 shared papers)Catherine A. Wakeman (2 shared papers)Amir Rattner (1 shared paper)Divya Sharma (1 shared paper)Jeremy Nathans (1 shared paper)Timothy J. Ward (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Journal of Medicinal Chemistry (3 papers)Journal of Bacteriology (3 papers)Biochemistry (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Charles E. Dann
39 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 1.2k
- Physiology 365
- Cancer Research 189
- Spectroscopy 217
- Genetics 339
Countries citing papers authored by Charles E. Dann
This map shows the geographic impact of Charles E. Dann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Dann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Dann more than expected).
Fields of papers citing papers by Charles E. Dann
This network shows the impact of papers produced by Charles E. Dann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Dann. The network helps show where Charles E. Dann may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles E. Dann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 394 | |
| 2 | 2005 | 378 | |
| 3 | 2007 | 324 | |
| 4 | 2013 | 187 | |
| 5 | 2002 | 174 | |
| 6 | 2009 | 121 | |
| 7 | 2009 | 114 | |
| 8 | 1995 | 95 | |
| 9 | 1996 | 91 | |
| 10 | 2012 | 91 | |
| 11 | 2013 | 83 | |
| 12 | 2013 | 74 | |
| 13 | 2007 | 57 | |
| 14 | 2011 | 55 | |
| 15 | 2014 | 54 | |
| 16 | 2000 | 50 | |
| 17 | 2019 | 50 | |
| 18 | 2017 | 49 | |
| 19 | 2005 | 46 | |
| 20 | 2015 | 38 |
About Charles E. Dann
Charles E. Dann is a scholar working on Molecular Biology, Rheumatology, Organic Chemistry, Genetics and Materials Chemistry, having authored 39 papers that have together received 2.8k indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Enzyme Structure and Function (7 papers), Folate and B Vitamins Research (6 papers), Bacterial Genetics and Biotechnology (6 papers), Biochemical and Molecular Research (5 papers), Protein Structure and Dynamics (5 papers), RNA and protein synthesis mechanisms (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Physiology (365 citations), Cancer Research (189 citations), Spectroscopy (217 citations) and Genetics (339 citations). Charles E. Dann has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Daniel J. Leahy, Richard K. Bruick, Wade C. Winkler, Catherine A. Wakeman, Amir Rattner, Divya Sharma, Jeremy Nathans, Timothy J. Ward, J. Deisenhofer and David P. Giedroc. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry, Journal of Bacteriology, Biochemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.